TEVA PHARMACEUTICAL INDUSTRIES LIMITED Current Federal Tax Expense (Benefit)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Current Federal Tax Expense (Benefit) of $154.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current federal tax expense (benefit) for fiscal 2025 was $154.00M, a 76.52% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current federal tax expense (benefit) for fiscal 2024 was $656.00M, a 1722.22% increase from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED current federal tax expense (benefit) for fiscal 2023 was $36.00M.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $154.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $656.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $36.00M 10-K · filed 2026-02-03 |